Man Huang Selected Research

Man Huang Research Topics

Disease

13	Infections 01/2022 - 01/2016
12	Sepsis (Septicemia) 01/2021 - 04/2011
6	Neoplasms (Cancer) 01/2022 - 08/2017
6	Inflammation (Inflammations) 01/2021 - 03/2003
4	Acute Coronary Syndrome 01/2022 - 07/2002
4	Septic Shock (Toxic Shock Syndrome) 12/2021 - 01/2018
3	Critical Illness (Critically Ill) 03/2022 - 08/2018
3	Traumatic Brain Injuries (Traumatic Brain Injury) 12/2012 - 08/2010
3	Cerebral Hemorrhage 08/2012 - 01/2010
2	Heart Failure 04/2022 - 11/2021
2	Melanoma (Melanoma, Malignant) 01/2022 - 01/2021
2	COVID-19 01/2022 - 08/2021
2	Triple Negative Breast Neoplasms 01/2021 - 01/2021
2	Respiratory Insufficiency (Respiratory Failure) 01/2021 - 08/2019
2	Squamous Cell Carcinoma (Epidermoid Carcinoma) 01/2021 - 09/2013
2	Respiratory Distress Syndrome (Acute Respiratory Distress Syndrome) 11/2020 - 10/2019
2	Pneumonia (Pneumonitis) 10/2019 - 01/2018
2	Cognitive Dysfunction 01/2014 - 05/2013
2	Necrosis 05/2013 - 12/2012
2	Decapitation 10/2011 - 06/2011
2	Brain Injuries (Brain Injury) 06/2011 - 01/2010
2	Hemorrhage 08/2010 - 01/2010
1	Acute Kidney Injury (Acute Renal Failure) 04/2022
1	Pulmonary Embolism 01/2022
1	Healthcare-Associated Pneumonia 01/2022
1	ST Elevation Myocardial Infarction 01/2022
1	Hypertension (High Blood Pressure) 01/2022
1	Unstable Angina 01/2022
1	Pseudomonas Infections 01/2022
1	Coronary Disease (Coronary Heart Disease) 01/2022
1	Breast Neoplasms (Breast Cancer) 12/2021
1	Abdominal Aortic Aneurysm 11/2021
1	Aneurysm (Aneurysms) 11/2021

Drug/Important Bio-Agent (IBA)

8	Carbapenems (Carbapenem Antibiotics)IBA 01/2022 - 01/2018
7	CytokinesIBA 01/2021 - 03/2003
5	Anti-Bacterial Agents (Antibiotics)IBA 01/2022 - 01/2018
4	Polymyxin B (Aerosporin)FDA LinkGeneric 04/2022 - 01/2019
4	Pharmaceutical PreparationsIBA 11/2021 - 01/2019
4	InterleukinsIBA 01/2021 - 11/2003
4	Biomarkers (Surrogate Marker)IBA 01/2021 - 01/2010
4	Interleukin-6 (Interleukin 6)IBA 01/2014 - 07/2003
3	RNA (Ribonucleic Acid)IBA 01/2022 - 08/2010
3	Proteins (Proteins, Gene)FDA Link 02/2021 - 01/2014
3	LipopolysaccharidesIBA 11/2020 - 10/2011
2	2'- deoxythymidylyl- (3'- 5')- 2'- deoxyadenosine (d(AT))IBA 01/2022 - 01/2014
2	Tigecycline (Tygacil)FDA Link 01/2022 - 02/2018
2	CholesterolIBA 11/2021 - 02/2021
2	CreatinineIBA 02/2021 - 01/2014
2	InflammasomesIBA 01/2021 - 06/2019
2	EndotoxinsIBA 11/2020 - 04/2011
2	salicylhydroxamic acid (SHAM)IBA 06/2020 - 01/2014
2	Interleukin-1 (Interleukin 1)IBA 01/2020 - 01/2019
2	mangostinIBA 06/2019 - 02/2016
2	Colistin (Coly-Mycin)FDA Link 01/2019 - 08/2018
2	Messenger RNA (mRNA)IBA 01/2014 - 08/2010
2	Toll-Like Receptor 4IBA 12/2012 - 06/2011
2	oxymatrineIBA 08/2012 - 06/2011
2	NF-kappa B (NF-kB)IBA 08/2012 - 06/2011
2	Peptide Hydrolases (Proteases)FDA Link 11/2003 - 03/2003
2	Histamine (Histamine Dihydrochloride)FDA Link 11/2003 - 07/2002
1	dimethylaniline monooxygenase (N-oxide forming) (flavin-containing monooxygenase)IBA 04/2022
1	trimethyloxamine (trimethylamine N-oxide)IBA 04/2022
1	pro-brain natriuretic peptide (1-76)IBA 01/2022
1	InterferonsIBA 01/2022
1	TicagrelorIBA 01/2022
1	Aspirin (Acetylsalicylic Acid)FDA LinkGeneric 01/2022
1	Clopidogrel (Plavix)FDA Link 01/2022
1	AntigensIBA 01/2022
1	Histones (Histone)IBA 01/2022
1	DNA (Deoxyribonucleic Acid)IBA 01/2022
1	Lysine (L-Lysine)FDA Link 01/2022
1	ceftazidime drug combination avibactamIBA 01/2022
1	CohesinsIBA 01/2022
1	gamma Subunit Interferon-Stimulated Gene Factor 3 (Interferon Stimulated Gene Factor 3, gamma Subunit)IBA 01/2022
1	Virulence Factors (Pathogenicity Factors)IBA 12/2021
1	HDL CholesterolIBA 11/2021
1	oxidized low density lipoproteinIBA 11/2021
1	LDL CholesterolIBA 11/2021
1	LipidsIBA 11/2021
1	Triglycerides (Triacylglycerol)IBA 11/2021
1	N-Acetylneuraminic Acid (Sialic Acid)IBA 11/2021
1	lactate dehydrogenase C4IBA 02/2021
1	Lactic Acid (Lactate)FDA LinkGeneric 02/2021
1	Bile Acids and Salts (Bile Acids)IBA 02/2021

Therapy/Procedure

9	Therapeutics 01/2022 - 04/2011
4	Lung Transplantation 01/2022 - 10/2019
2	Critical Care (Surgical Intensive Care) 03/2022 - 08/2018
2	Transplantation 01/2022 - 01/2021
2	Extracorporeal Membrane Oxygenation 01/2022 - 10/2019
2	Artificial Respiration (Mechanical Ventilation) 02/2021 - 01/2018
2	Punctures 10/2020 - 01/2017
2	Ligation 10/2020 - 01/2017
2	Intraperitoneal Injections 10/2011 - 06/2011
1	Chinese Traditional Medicine (Traditional Chinese Medicine) 01/2022
1	Perioperative Care 01/2022
1	Percutaneous Coronary Intervention 01/2022
1	Salvage Therapy 01/2022
1	Thrombectomy 01/2022
1	Resuscitation 12/2021
1	Continuous Renal Replacement Therapy 02/2021